Pharmaceutical giant AstraZeneca uncapped Evinova, a health tech business offering other drug companies paid access to its digital clinical trial tools.
Why it matters: Clinical trials are dominated by costly and slow-moving studies run largely by elite medical centers, and dozens of startups have emerged with ideas on how to diversify and streamline them.
